Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Pulse Biosciences, Inc.    PLSE

PULSE BIOSCIENCES, INC.

(PLSE)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
03/01/2021 03/02/2021 03/03/2021 03/04/2021 03/05/2021 Date
29.45(c) 29.37(c) 27.77(c) 25.15(c) 25.68(c) Last
75 216 176 163 133 631 152 730 269 865 Volume
+0.68% -0.27% -5.45% -9.43% +2.11% Change
More quotes
Financials (USD)
Sales 2020 - - -
Net income 2020 - - -
Net Debt 2020 - - -
P/E ratio 2020 -
Yield 2020 -
Sales 2021 4,25 M - -
Net income 2021 - - -
Net Debt 2021 - - -
P/E ratio 2021 -
Yield 2021 -
Capitalization 669 M 669 M -
Capi. / Sales 2020 -
Capi. / Sales 2021 158x
Nbr of Employees 82
Free-Float 51,7%
More Financials
Company
Pulse Biosciences, Inc. is a clinical-stage medical device company using a platform technology called Nano-Pulse stimulating (NPS). NPS is a non-thermal, precise, focal drug-free electroceutical treatment technology that initiates cell death within treated tissue. NPS provides treatment in a range of immuno-oncology, dermatology and aesthetic applications. It offers treatment for minimally invasive applications,... 
More about the company
All news about PULSE BIOSCIENCES, INC.
03/05PULSE BIOSCIENCES  : to Participate in Upcoming Investor Conferences
BU
02/22PULSE BIOSCIENCES, INC.  : Results of Operations and Financial Condition, Financ..
AQ
02/22PULSE BIOSCIENCES  : Reports Fourth Quarter and Full Year 2020 Financial Results
BU
02/19PULSE BIOSCIENCES  : Announces First CellFX Procedures Performed in Europe as Pa..
BU
02/16PULSE BIOSCIENCES  : Announces Start of Controlled Launch of the CellFX System®
BU
02/12PULSE BIOSCIENCES  : Schedules Fourth Quarter and Full Year 2020 Financial Resul..
BU
02/10PULSE BIOSCIENCES, INC.  : Other Events (form 8-K)
AQ
02/04PULSE BIOSCIENCES, INC.  : Entry into a Material Definitive Agreement, Other Eve..
AQ
02/04PULSE BIOSCIENCES, INC.  : Announces At-The-Market Equity Offering Program
BU
02/03PULSE BIOSCIENCES, INC.  : Other Events, Financial Statements and Exhibits (form..
AQ
02/03PULSE BIOSCIENCES  : Secures FDA Clearance for Nano-Pulse Stimulation Technology
MT
02/03PULSE BIOSCIENCES  : Announces FDA Clearance for the CellFX® System
BU
01/26PULSE BIOSCIENCES  : HC Wainwright Adjusts Pulse Biosciences's Price Target to $..
MT
01/25PULSE BIOSCIENCES  : Secures CE Mark for CellFX System
MT
01/25PULSE BIOSCIENCES, INC.  : Other Events, Financial Statements and Exhibits (form..
AQ
More news
News in other languages on PULSE BIOSCIENCES, INC.

- No features available -

More news
Analyst Recommendations on PULSE BIOSCIENCES, INC.
More recommendations
Chart PULSE BIOSCIENCES, INC.
Duration : Period :
Pulse Biosciences, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PULSE BIOSCIENCES, INC.
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Average target price 45,72 $
Last Close Price 25,68 $
Spread / Highest target 78,0%
Spread / Average Target 78,0%
Spread / Lowest Target 78,0%
Managers and Directors
NameTitle
Darrin R. Uecker President, Chief Executive Officer & Director
Sandra A. Gardiner CFO, Secretary, Treasurer & Executive VP-Finance
Robert William Duggan Chairman
Richard Nuccitelli Chief Science Officer
David Danitz Vice President-Engineering
Sector and Competitors
1st jan.Capitalization (M$)
PULSE BIOSCIENCES, INC.7.63%669
THERMO FISHER SCIENTIFIC-4.06%175 974
DANAHER CORPORATION-1.71%155 510
INTUITIVE SURGICAL, INC.-12.80%83 977
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.-9.39%72 243
ILLUMINA, INC.7.80%58 192